Susquehanna International Group
RLAY icon

Susquehanna International Group’s Relay Therapeutics RLAY Stock Holding History

Susquehanna International Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-28,600
Closed -$242K – 13957
2025
Q4 		$242K Buy
+28,600
New +$204K ﹤0.01% 10446
2025
Q2 		– Sell
-17,500
Closed -$45.9K – 13564
2025
Q1 		$45.9K Buy
17,500
+6,300
+56% +$24.7K ﹤0.01% 11893
2024
Q4 		$46.1K Sell
11,200
-11,200
-50% -$60.9K ﹤0.01% 11711
2024
Q3 		$159K Buy
22,400
+5,000
+29% +$37.4K ﹤0.01% 10689
2024
Q2 		$113K Buy
+17,400
New +$119K ﹤0.01% 10930
2023
Q3 		– Sell
-53,100
Closed -$667K – 12818
2023
Q2 		$667K Sell
53,100
-55,300
-51% -$688K ﹤0.01% 7633
2023
Q1 		$1.79M Buy
+108,400
New +$1.94M ﹤0.01% 5389
2022
Q4 		– Sell
-65,600
Closed -$1.47M – 13483
2022
Q3 		$1.47M Buy
+65,600
New +$1.44M ﹤0.01% 5655
2022
Q2 		– Sell
-49,300
Closed -$1.48M – 13790
2022
Q1 		$1.48M Sell
49,300
-45,000
-48% -$1.09M ﹤0.01% 6175
2021
Q4 		$2.9M Buy
94,300
+61,100
+184% +$1.93M ﹤0.01% 4712
2021
Q3 		$1.05M Buy
+33,200
New +$1.12M ﹤0.01% 7436

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Susquehanna International Group's RLAY Position: Q1 2026 in Review

Susquehanna International Group reduced its Relay Therapeutics (RLAY) stake by 34% in Q1 2026, selling an estimated $678K and leaving 147,158 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #6953.

Susquehanna International Group first reported a position in RLAY in Q4 2020 and has held it in 22 quarters since. The position peaked at $4.2M in Q1 2023. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Susquehanna International Group held 147,158 shares of Relay Therapeutics worth $1.46M as of Q1 2026.
  • Susquehanna International Group sold 75,771 Relay Therapeutics shares in Q1 2026, an estimated $678K.
  • Relay Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6953 holding.
  • Susquehanna International Group first reported a position in Relay Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Susquehanna International Group's Relay Therapeutics position peaked at $4.2M in Q1 2023.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.